A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial

Fluorouracil and platinum are considered the standard treatment options for advanced gastric cancer. Docetaxel is also an effective agent and it shows no cross-resistance with fluorouracil and platinum. The combination treatment of docetaxel with fluorouracil and platinum has been explored, but it d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Chen, Ming-Huang, Lin, Johnson, Hsiao, Chin-Fu, Shan, Yan-Shen, Chen, Yeu-Chin, Chen, Li-Tzong, Liu, Tsang-Wu, Li, Chung-Pin, Chao, Yee
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2016
Témata:
5700
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998286/
https://ncbi.nlm.nih.gov/pubmed/26817912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002565
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky